BPC-157 Capsules: What Oral Forms Actually Do, and Who Sells Them Honestly

BPC-157 capsules are sold everywhere now, and most of them are marketed as if they work just like the shot. The problem: no published study has ever measured how much oral BPC-157 reaches a human's bloodstream. Zero. The "90% oral bioavailability" and "30x more absorbable" claims you'll see on product pages trace to marketing copy, not pharmacokinetic data.

That doesn't make capsules useless. It makes them a different tool. Oral BPC-157 has a real, mechanistically sound rationale for gut-local support, and capsules and tablets are the needle-free way to take it. What they are not is a measured substitute for subcutaneous injection.

This guide does two things. First, it gives you the honest bioavailability picture, including why "hold it under your tongue" has weak physiology behind it. Then it grades the actual capsule and tablet sellers on one question: do they show you a real COA? We grade on receipts. Affiliate ties don't move the grade, and we say so where one exists. If you want the injectable side of this comparison, that lives in our BPC-157 vendor coverage.

Oral vs Injectable BPC-157: The Bioavailability Reality

Route of administration decides what your tissue actually receives. Injectable BPC-157 bypasses your digestive tract entirely and delivers the peptide into circulation with near-complete efficiency. That is why nearly every preclinical study uses an injection. The one pharmacokinetic dataset that exists, from He et al., measured intramuscular bioavailability at roughly 14 to 19 percent in rats and 45 to 51 percent in dogs. Those are intramuscular figures in animals, not oral numbers in humans.

Here's why oral is worth discussing at all. BPC-157 is unusually stable in stomach acid. It survives more than 24 hours in human gastric juice, a property that destroys most peptides within minutes. Its proline-rich sequence gives it conformational rigidity that resists enzymatic cleavage. So a swallowed capsule can reach and act on the gut lining intact, which is the legitimate reason oral BPC-157 has a rationale for GI-local effects. Animal models show consistent activity on gastric ulcers, colitis markers, and intestinal permeability.

Stability is not the same as systemic absorption. Surviving the stomach does not mean the peptide crosses the intestinal wall into your blood in meaningful amounts. Human oral bioavailability for BPC-157 has never been formally measured. For most peptides it sits below 1 to 5 percent, and at roughly 1,419 daltons, BPC-157 is a large molecule to move through the gut wall without help.

Sublingual deserves a quick note, because bpc-157 sublingual products promise an injection-like shortcut. The physiology is weak. Efficient sublingual absorption generally requires a molecular weight under about 500 daltons. BPC-157 is nearly three times that. Whatever effect a sublingual product delivers most likely comes from the portion you swallow, riding the same gut-stability mechanism as a capsule.

The decision rule is simple. Want gut or GI support, or just a needle-free option? Oral BPC-157 is a reasonable choice. Want maximal systemic delivery for tendon, joint, or muscle recovery? Injection is the studied route, and it isn't close.

The 90% Oral Bioavailability Claim, Fact-Checked

You're about to be upsold on a "special formulation." Vendors selling BPC-157 arginate salt (and sometimes SNAC-enhanced) capsules advertise around 90 percent oral bioavailability, or "30x more absorbable" than the standard form. Those numbers have zero peer-reviewed basis.

A PubMed search for BPC-157 arginate bioavailability returns no studies. None. The acetate form is what's used in essentially all published research, and arginate produces no additional published absorption data of its own. The "90%" and "30x" figures are vendor marketing, full stop. The free peptide's gastric stability comes from its own structure, not from the salt it's paired with, so arginate doesn't add a unique survival advantage the molecule didn't already have.

The honest version of the argument is narrower. Arginine as a counter-ion does buffer the solution toward neutral pH (roughly 6.5 to 7.5 versus acetate's 4.5 to 5.5), which is a plausible mechanistic reason it could help peptide survival in some conditions. Permeation enhancers like SNAC are real technology used in approved oral peptide drugs. But "reasonable mechanism" and "measured in humans for BPC-157" are different statements, and the gap between them is where the marketing lives.

What this means for your wallet: don't pay a parity premium. If you choose oral BPC-157, choose it for gut-local support or convenience, and judge the product on its certificate of analysis, not on a formulation buzzword. The verdict on the 90 percent claim: unsupported, and a reason to be more skeptical of the vendor, not less.

How We Graded These Capsules

The grades below have teeth because they rest on one thing: published, verifiable COA evidence. We don't test peptides. We test whether a vendor is willing to show you the receipts, and what those receipts actually cover.

For a capsule or tablet, a good COA shows identity confirmation (LC-MS matched to BPC-157's 1,419.55 Da mass) and HPLC purity, ideally 98 to 99 percent or higher. Because this is a product you swallow, the better certificates add safety panels: heavy metals, microbial or sterility, and endotoxin. The label also has to state mcg per unit and count so you can compute cost per serving. Our full COA verification methodology walks through every field.

Three things drop a grade fast:

• A "lab tested" claim with no document you can open and read
• An implausible bioavailability or purity figure standing in for an actual COA
• Listings sold through Amazon or eBay third-party storefronts with no batch-matched certificate

On disclosure: some links here may be affiliate links. Grades use only independently verifiable signals, and affiliate status changes nothing. We mark it where it applies. Two names people ask about didn't make the cut. Biotech Peptides sells reconstitutable vials only, with no oral capsule or tablet form. Body of Harmony's capsule product page was dead at the time of writing, so there was nothing verifiable to grade.

Eternal Peptides: BPC-157 Tablets (500 mcg x 50)

A named, independent lab on an oral BPC-157 product is rarer than it should be. Eternal Peptides puts one on the table: its BPC-157 tablets are tested by Janoshik, with a live COA page and a stated purity of 99 percent or higher. Tablets, 500 mcg per unit, 50 per bottle.

Disclosure first, since it matters: Eternal Peptides is in our affiliate program. It does not affect the grade. The grade comes from the COA, and the COA is the strongest part of this listing.

What to verify before you buy: confirm the Janoshik report shows both identity (mass spec matched to BPC-157) and HPLC purity, and check whether the certificate extends to heavy metals or microbial testing, which matters for anything you ingest. The product page returned an access error on our last check, so treat the price as "check current listing" rather than a fixed number. At 500 mcg x 50, a one-per-day routine runs about 50 days per bottle, which helps the per-serving math once you have the live price.

One honest caveat: tablet pressing introduces excipients and compression that a lyophilized vial avoids, and none of that changes the underlying fact that human oral PK for BPC-157 is unmeasured. A named lab tells you the tablet contains what it says. It doesn't tell you how much reaches your blood.

Grade: A-. Named third-party lab, high stated purity, verifiable COA. Confirm the safety-panel scope to push it higher.

• Best for: needle-free users who want a named-lab COA behind their tablets.
• Skip if: you need systemic, tendon-repair dosing, which is an injection job.

ProHealth Longevity: BPC-157 Capsules (500 mcg x 60)

This is the receipts other capsule sellers don't show. ProHealth Longevity's BPC-157 arginate capsules (500 mcg, 60 count, $119.95) carry the most complete COA in this set: a batch-specific certificate dated April 2026 covering potency, purity, heavy metals, microbial pathogens, and residual solvents, produced in an FDA-registered, GMP-certified facility.

For a product you swallow daily, that breadth is the whole point. An HPLC purity number tells you what fraction of the material is the target peptide. It says nothing about lead, arsenic, or bacterial load. Heavy metals and microbial panels catch contamination purity testing never sees, and residual solvents matter for anything synthesized and processed at scale. Most capsule vendors stop at purity. ProHealth doesn't.

The cost math: $119.95 for 60 capsules is $2.00 per capsule, the priciest per-unit option here. Per 1,000 mcg, that works out to about $3.99, the cheapest effective rate among the tested vendors once you normalize for dose. It's framed as a dietary supplement rather than research-use-only, with a standard hypromellose capsule and inert fillers.

The caveat we won't drop: comprehensive testing tells you the capsule is clean and correctly dosed. It does not tell you the peptide reaches systemic circulation. ProHealth rides the same unproven oral-absorption story as everyone else on this page. Pay for the testing breadth, not for an implied injection equivalence that no one has measured.

ProHealth is not an affiliate, and that changes nothing about the grade.

The verdict: if your priority is the safest-tested ingested product and price is secondary, this is the one to beat. Grade: A.

Limitless Life Nootropics: BPC-157 Capsules (250 mcg x 60)

Starting low is easier when the capsule is half the size. Limitless Life Nootropics sells BPC-157 arginate capsules at 250 mcg, 60 count, $103.39, with a published COA covering purity (98.5 percent or higher), endotoxin, and sterility. That endotoxin-plus-sterility pairing is uncommon at this dose and a genuine point in its favor.

The 250 mcg unit is the appeal: it lets you titrate up gradually instead of committing to a 500 mcg dose on day one. The trade-off is throughput. At two capsules a day, a 60-count bottle lasts 30 days.

Do the cost math honestly. At $103.39 for 60, that's about $1.72 per capsule, which looks cheap until you account for the dose. Per 1,000 mcg, you're paying roughly $6.89, versus about $3.99 per 1,000 mcg on ProHealth's 500 mcg capsules. Lower per-capsule price, higher effective cost per microgram delivered. If you're titrating short-term, that's a fair price for control. If you settle on a 500 mcg daily target, a higher-dose product is more economical.

One clarification worth making: this is Limitless Life Nootropics, not "Limitless Biotech," a different vendor people regularly confuse it with. Check the URL before you buy.

Grade: B+. Triple-tested COA with endotoxin and sterility, transparent specs, a slightly older purity floor than the top tier.

• Best for: conservative users who want to start low and titrate with a tested product.
• Skip if: you already know you want 500 mcg daily and care about cost per microgram.

InfiniWell: BPC-157 Capsules With a Permeation Enhancer

SNAC is the same absorption enhancer class used in FDA-approved oral semaglutide (Rybelsus), so the idea behind InfiniWell's capsules isn't snake oil. It pairs BPC-157 arginate with SNAC (salcaprozate sodium), which transiently loosens intestinal tight junctions to help peptides cross the gut wall. The line comes in Original, Rapid, and Delayed-release formats and at two strengths: 250 mcg ($109.95) and a 500 mcg Pro ($159.95), 60 count, with a COA available.

The honest read on SNAC: it's validated for the drugs it was studied in, not for BPC-157. No published study confirms it boosts BPC-157's oral bioavailability specifically. So you're buying a sound mechanism with no BPC-157-specific human data behind it, at the highest prices in this comparison. The 500 mcg Pro at $159.95 works out to roughly $2.67 per capsule.

The release-format options are the interesting part. Rapid targets the upper GI tract. Delayed is engineered to release lower in the intestine, a thoughtful touch if your target is lower-GI tissue.

The verdict: pay the InfiniWell premium only if the permeation-enhancer concept specifically appeals to you and the budget is comfortable. The COA still drives the grade, not the formulation story.

Quick comparison: ProHealth tests broader for less per capsule, and Eternal Peptides offers a named lab on cheaper tablets. InfiniWell wins on delivery-tech ambition, not on price or testing breadth. Grade: B.

Healthletic: When the Bioavailability Claim Is the Red Flag

A product that leads with "99.9% oral bioavailability" should make you close the tab. Healthletic markets exactly that figure on its BPC-157 arginate capsules (500 mcg, 60 count, $105.95, two capsules per 1,000 mcg serving). The number is the problem, and it's a useful one, because it shows every red flag from our grading section in a single listing.

A 99.9 percent oral bioavailability figure for a roughly 1,419 Da peptide is not credible. As covered above, most peptides land under 5 percent oral, BPC-157's human oral absorption has never been measured, and nothing about the arginate salt changes that physiology. The claim contradicts the entire published record.

The deeper issue isn't the marketing number, it's what's missing behind it. Independent COA verification isn't confirmed here. Third-party testing is asserted but, per the supplement-tracking aggregator SuppCo, not independently verified at the time of writing. A high star count and a large customer total don't substitute for a batch-matched certificate you can open and read. A bioavailability stat is something a vendor types into a product page. A COA is something a lab signs.

The direct recommendation: when a listing leads with a bioavailability stat instead of a COA link, treat the stat as marketing and move on. This is the listing that proves this guide isn't pay-to-play. Grade: D.

Oral BPC-157 Dosage: What the Labels and Cycles Look Like

You came for numbers, so here are the ones the market actually uses, framed as conventions rather than medical advice. Commercial capsule products cluster at 250 to 500 mcg per unit, taken once or twice daily. The standard label instruction is to dose on an empty stomach, roughly 20 to 30 minutes before food. Cycle lengths of 4 to 8 weeks with a 1 to 2 week break between cycles are common market practice, and users commonly report noticing effects somewhere around 7 to 10 days in.

Some GI-focused protocols push toward 1,000 mcg (1 mg) daily. Oral doses are often set 2 to 4 times higher than injectable doses, a practical compensation for the absorption losses discussed earlier, not a proven equivalence.

The budgeting math follows directly from dose and count:

• A 250 mcg x 60 bottle at two per day is a 30-day supply.
• A 500 mcg x 50 tablet bottle at one per day is a 50-day supply.
• A 500 mcg x 60 capsule bottle at one per day is a 60-day supply.

Pair those against the per-serving prices above and you can budget a full cycle before you buy. The oral bpc 157 dosage ranges here are label and market conventions extrapolated from animal data. No human clinical dose has been established, BPC-157 is not FDA-approved, and everything here is sold for research use. Describe, don't prescribe applies to you too: this is context for evaluating products, not a protocol to follow.

The Bottom Line

Oral BPC-157 is a legitimate choice for two things: gut-directed support, where the peptide acts on tissue it physically contacts, and needle-free convenience. It is not a measured substitute for injection. If your goal is systemic tendon, joint, or muscle recovery, the injection route is the one with the evidence, and oral can't be sold to you as its equal honestly. That single distinction separates an honest vendor from a marketing page.

If you've decided oral is right for you, the pick comes down to receipts:

• Want the most complete safety testing? Buy ProHealth Longevity (A). Broadest COA in the set: heavy metals, microbial, residual solvents, and the cheapest effective rate per 1,000 mcg among the tested vendors.
• Want a named third-party lab on tablets, at likely better value? Buy Eternal Peptides (A-, affiliate, disclosed). Janoshik-tested, 99 percent-plus purity.
• Want to start low and titrate? Buy Limitless Life Nootropics (B+). 250 mcg units, endotoxin and sterility tested.
• Intrigued by permeation-enhancer tech and budget-flexible? Consider InfiniWell (B).
• Saw a "99.9% bioavailability" claim? Walk away. That's Healthletic's D, and the lesson generalizes to any listing that leads with a stat instead of a certificate.

For the full graded list across every vendor we cover, see our vendor directory. For the injectable comparison and why route changes everything, see our BPC-157 coverage.

FAQ

Do BPC-157 capsules actually work?

For gut-local effects, the rationale is sound. BPC-157 survives stomach acid (stable 24-plus hours in human gastric juice) and acts directly on the mucosa it contacts, with consistent animal-model evidence for gastric ulcers, IBD models, and intestinal permeability. For systemic effects like tendon or joint repair, human oral absorption is unmeasured and likely very low. No human clinical trials exist for any route.

Oral vs injectable BPC-157, which is better?

It depends on your target. For GI conditions, oral capsules deliver the peptide straight to the affected tissue, the logical route. For systemic goals (joints, tendons, muscle, peripheral inflammation), injection is the studied route, because it reaches circulation with near-complete efficiency while oral systemic delivery is unproven in humans. Match the route to the target.

Is BPC-157 sublingual worth it?

Probably not for a systemic edge. At roughly 1,419 daltons, BPC-157 is nearly three times the approximately 500 Da ceiling for efficient sublingual absorption, so the physiology is weak. Any effect you get most likely comes from the portion you swallow, which means a sublingual product offers little advantage over a standard capsule and no measured benefit over injection.

Is BPC-157 legal? Is it banned?

BPC-157 is not FDA-approved for any use and is not a legal dietary supplement; it's sold for research use with "not for human consumption" labeling. Its compounding status shifted in 2026 (FDA removed it from Category 2 in April 2026, with a PCAC review scheduled for July 2026). For tested athletes, WADA prohibits it under S0 at all times, in and out of competition, and no therapeutic use exemption is available.

How do I read a BPC-157 capsule COA?

Confirm four things. Identity, via LC-MS matched to BPC-157's 1,419.55 Da mass. Purity, via HPLC at 98 percent or higher. A lot number that matches your bottle. And a named, independently verifiable lab. For an ingested product, the better certificates also include heavy metals and microbial or sterility testing. If the purity or content doesn't match the mcg on the label, or there's no document to open, treat the listing as unverified.